Rohini Deshpande serves as senior vice president, Operations, Obesity at Amgen, where she leads Operations execution and launch readiness across the company’s obesity portfolio. She is responsible for bringing together Operations capabilities and cross-functional teams to advance critical milestones, manage risk and prepare Amgen to deliver its obesity medicines to patients at scale.

Deshpande brings more than 25 years of experience at Amgen spanning Research and Operations. She has held leadership roles across Operations Commercialization, Drug Substance Technologies and Attribute Sciences, connecting scientific innovation, manufacturing and commercialization to accelerate the delivery of medicines across Amgen’s portfolio. As site head for Amgen Massachusetts, she also helped reposition the site as Amgen’s East Coast Innovation Center for Operations.

Throughout her career, she has advanced next-generation manufacturing technologies and capabilities, led global teams and helped strengthen how Amgen moves medicines from development through commercialization to serve patients.

Deshpande is a recipient of the Healthcare Businesswomen’s Association Luminary Award and actively mentors emerging leaders. She earned a Ph.D. in Biology from SUNY Binghamton and completed postdoctoral research at UCLA and the University of Michigan.